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Allelic exclusion of lymphocyte antigen receptor chains has been hypothesized as a mechanism 
developed by the immune system to ensure efficient lymphocyte repertoire selection and tight 
control of lymphocyte specificity. It was effectively shown to be operative for both the immuno- 
globulin (Ig) and the T  cell receptor (TCR) B chain genes. Our present observations suggest 
that close to 1% of human T  lymphocytes escape this allelic control, and express two surface 
TCK B chains with distinct superantigenic reactivities. Since this high frequency of dual ~ chain 
expressors did not result in any dramatic immune dysregulations, these results question the need 
for a mechanism ensuring clonal monospecificity through allelic exclusion. 
T  mphocyte antigen receptors are composed of two vari- 
1./ able glycoprotein subunits, the Ig heavy and light chains 
on B cells and the TCK ot and/3 or y  and ~ chains on T 
cells. The genes coding for Ig and TCK chains are formed 
through somatic rearrangement of V, D, and J elements (for 
reviews see references I and 2). Given its diploid nature, any 
lymphocyte clone could theoretically express up to four dis- 
tinct combinations of antigen receptor chains on its surface. 
Since donal plurispecificity, possibly resulting from expres- 
sion of multiple antigen receptors on the same cell, is ex- 
pected to lead to immune dysregulations (that is, autoimmu- 
nity), control processes ensuring allelic exclusion of antigen 
receptor chains were postulated more than a decade ago, and 
their existence demonstrated through elegant Ig and TCK 
transgenic mouse models (3-5). 
More recently it has become clear that the stringency of 
aUelic exclusion greatly differs from one antigen receptor chain 
gene to another. In the case of TCK/~ chain genes, expres- 
sion of any productively rearranged gene prevents further rear- 
rangement in the B locus, a process referred to as "genotypic" 
exclusion (6).  Such a genotypic control is illustrated by the 
arrest of endogenous TCR B gene rearrangements in mice 
carrying a functional or truncated B transgene (5, 7). How- 
ever, similar transgenic studies have failed to demonstrate a 
dramatic influence of functional ol transgenes on the occur- 
rence of rearrangements within endogenous TCK  o~ loci 
(8-12). Moreover, studies performed on normal T cells have 
revealed the expression of distinct productive cz transcripts 
(13) or even distinct surface cz chains (14) on a fraction of 
murine and human T  cell clones. 
Although lack of aUelic exclusion of ol chains can result 
in a violation of the "one cell,  one receptor" rule, current 
ontogenic models suggest that dual ol chain expression would 
have limited physiological consequences. Experiments with 
normal and transgenic T cells suggest that a developing lym- 
phocyte will keep on rearranging its ot loci until it produces 
a TCR o~ chain able to pair with the available TCK ~ chain 
and form a TCK showing sufficient affinity for selfMHC-pep- 
tide complexes (12, 13, 15). The corollary to this hypothesis, 
which proposes a close coupling between arrest of TCK cz 
gene rearrangements within the thymocyte and its positive 
selection, is that any lymphocyte  carrying two distinct cz chains 
should systematically express one ot chain unable to form a 
selectable TCK, that is, with a physiologically relevant spec- 
ificity. Therefore lack of genotypic exclusion of TCK ot chain 
genes, which would merely be the consequence of a low fre- 
quency of selectable cx chains within the immature repertoire, 
should remain compatible with maintainance of clonal mono- 
specificity. This might not necessarily be true in the case of 
dual TCK B chain expression. First,  since rearrangements 
within TCR ~ loci are completed before production of TCK 
ol chains and subsequent ot/B TCK selection (for reviews see 
references 16 and 17), the two ot/B TCK present in dual B 
expressors could not in theory be sequentially tested for affinity 
to a given MHC-peptide complex. Second, because/~ chains, 
unlike o~ chains, display superantigenic reactivity (for a re- 
view see reference 18), dual TCR B chain expression should 
systematically lead to bispecificity, possibly hampering regu- 
lation of immune responses directed against exogenous su- 
perantigens. Hence, this may  justify the need for a tight con- 
trol of TCR/3 gene rearrangement, whose primary aim would 
be to ensure clonal monospecificity through maintainance of 
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into question by the present data, which suggest that a normal 
immune function can accommodate itself to a relatively high 
frequency of dual ~  chain expressors. 
Materials and Methods 
Antibodies.  The following mAbs were used for flow cytometry 
and sorting experiments: BMA031 (pan B), 360 (anti-vTg), LE89 
(anti-V/~3), IMMU157 (anti-V/~5.1), 36213 (anti-VBS.2), 3Dll 
(anti-V~5.3), OT145 (anti-V/~6.7), 56C5.2 (anti-V/~8), $511 (anti- 
V/~12.2), JU74 (anti-VB13.3), 417.5F3 (anti-V/~19), IG125 (anti- 
V/~21.3), and IMMU546 (anti-V/~22) (19-25). The V/~ nomencla- 
ture used is from reference 26. 
Generation oft Cell Lines and Clones.  PBL from healthy donors 
were sorted, cultured, and cloned as previously  described (27, 28). 
In brief, cells were incubated with TCR V-specific mAbs for 45 
rain, washed once, and rotated for 4 h at 4~  with magnetic beads 
coated with sheep anti-mouse Ig (Dynal, Oslo, Norway). After 
eight washes, bead-adherent calls were cultured in medium (RPMI 
1640, 10% human serum, 1 mM L-glutamine,  rib2, and leukoag- 
glutinin) and irradiated  PBL and B lymphoblastoid  cells. Beads were 
removed between day 5 and 8, cells were cultured further, and at 
day 14, they were subjected to a second immunomagnetic separa- 
tion. After two more weeks of culture, cells were cloned by lim- 
iting dilution in culture medium and irradiated  feeder cells. Growing 
colonies with a probability of monoclonality above 95% were kept 
for further analysis. 
Flow Cytometry Analysis.  Cells  were phenotyped  by indirect  im- 
munofluorescence  (IF)  1  as follows. Cells were incubated first with 
the unconjugated  mAbs (single  or pooled VB-specific  mAbs, 1:1,000 
ascites) at 4~  for 30 rain; second with FITC-conjugated rabbit 
anti-mouse Ig for 30 rain at 4~  third with normal mouse serum 
(1:10 dilution) for 10 rain at room temperature; fourth with bio- 
tinylated V~8-specific mAbs for 30 min at 4~  and fifth with 
PE-conjugated streptavidin for 30 rain at 4~  Between each incu- 
bation, cells were washed twice with PBS, 1% BSA. Cells were 
analyzed by flow cytometry on a FACScan  |  (Becton Dickinson & 
Co., Mountain View, CA) using LYSYS II software. To have an 
accurate estimate of infrequent subsets (representing <0.2% of the 
total population), 0.4  x  10 .6 events were accumulated  during the 
analysis. Staining background was reduced by gating out dead cells 
using propidium iodide (read on the FL3 channel). To reduce the 
proportion of doublets, which could represent up to 2% of the 
total population under "standard" conditions, two-color immuno- 
fluorescence (2C-IF) using a V38-specific mAb (red fluorescence) 
vs pooled, unconjugated mAbs directed against other VB regions 
(green fluorescence)  was performed on cells sorted with the V38- 
specific mAb. Under these conditions, because of the scarcity of 
"green-positive" events (<0.5%),  the proportion of doublets re- 
mained negligible (as demonstrated by control 2C-IF using a V38- 
specific mAb (red) vs an irrelevant V30-specific mAb (green) (see 
Fig. 1 C). 
Functional Assays.  Reactivity of T cell clones towards recom- 
binant staphylococcal  enterotoxins B and E (SEB and SEE) was 
assessed by proliferation  and lymphokine production assays. To this 
1  Abbreviations used in this ~per: IF, immunofluorescence;  rMFI, relative 
mean fluorescence  intensity; SEB, staphylococcal  enterotoxin B; SEE, 
staphylococcal enterotoxin E; SAg, superantigen; 2C-IF, two-color im- 
munofluorescence. 
end, resting T cells (taken more than 3 wk after the last mitogenic 
stimulation) (104 cells/well) were cocultured with irradiated MHC 
class II-positive Burkitt's lymphoma cells (RAJI) in the absence 
or presence of superantigen (SAg) (10 ng/ml).  Culture superna- 
tants, harvested  at day 1, were tested for leukemia  inhibiting factor 
(LIF) activity using DA.la  cells as described (29). T cell clone 
proliferation  was estimated at day 2 according to standard protocols 
(30). The specificity  and purity of the SAgs used were controlled 
by staining analysis of PBL cultured for 10 d in the presence of 
either culture medium alone or supplemented with recombinant 
SEB or SEE. In all instances, coculture with SEB lead to a dramatic 
amplification of V33, V/~12, V~814, and V~19 positive cells and 
disappearance ofVB5.1, V~8, V~/16, V817, and VB21 positive  cells 
within the culture, whereas reciprocal results were observed after 
coculture with SEE (our unpublished results), which is in accor- 
dance with previous reports (31, 32). 
Amplification and Sequencing of TCR Transc@ts.  Molecular  anal- 
ysis of TCR/~ transcripts was performed as previously described 
(33) on several T cell clones stained by two distinct VB-specific 
mAbs (in all cases, 100% of the cells were recognized by the two 
antibodies).  Reverse transcription  of  T  cell clone RNA, 
amplification,  and sequencing were performed using the following 
primers: VB3 (5'TAG AAT TCA TGG GAA TCA GGC TCC TC), 
VB5 (5'TAG AAT TCA TGG GCT CCA GGC TGC TCT GTT), 
VB6 (5'TCG AAT TCA CCA TGG GCA CCA GGC TCC TCT 
G), V~8 (5'ATG AT CGG GGA CTG GAG TTG CTC), V/~12 
(5'GAC AAA GGA GAA GTC TCA CAT GCC), VB19 (5'TAG 
AAT TCA TGA GCA ACC AGG TGC TCT GCT), VB21 (5'AAA 
GGA GTA GAC TCC ACT CTC), VB22 (5'AAT  TCT CAG TTG 
AAA GGC CTG), and CB (5'GGG AGA TCT CTG CTT CTG 
ATG GCT C). V, NDN, and J assignments were deduced from 
a comparative analysis  of cDNA sequences with those of germline 
elements. The VB and J/~ nomenclatures used were from Wilson 
et al. (26) and from Toyonaga et al. (34). 
Resuks 
Detection by Flow Cytometry of  Pe@heral T Lymphocytes Rec- 
ognized by Distinct V~-specific mAbs.  We recently described 
T cell clones expressing  two distinct TCR 3/chains on their 
surface, and demonstrated by 2C-IF that 1-7% of PBL were 
recognized by mAbs directed against distinct VT regions (33). 
In the course of this study, PBL-derived c~/3 T cell lines were 
analyzed in parallel by 2C-IF using mAbs directed against 
distinct V~8 regions, to compare the stringency of TCR 3/ 
vs. TCR ~ chain exclusion.  In light of previous studies sug- 
gesting a tight genotypic exclusion of TCK ~ chain genes 
(5), the proportion of cells recognized by two distinct VB- 
specific mAbs was expected to be low, if not negligible. There- 
fore we set up technical conditions that allowed detection 
and accurate quantification of cell subsets representing <0.2% 
of the total population (see Materials and Methods). Under 
these conditions, double positive cells recognized by both a 
VB8-specific mAb and a mAb specific for another V~/-region 
were reproducibly detected in all the cell lines studied (Fig. 
1 B and Table  1). 
Three possible artifacts could explain the above results: (a) 
a  binding  of the  FITC-conjugated antiserum  to  the PE- 
conjugated mAb; (b) a doublet discrimination problem (that 
is, due to lack of discrimination by the flow cytometer soft- 
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Figure 1.  Flow  cytometry analysis of cultured PBL lines using V~- 
specific mAbs. Shown are the dot-plot fluorescence  histograms (4  x 10  s 
events accumulated)  of VB8 + T cell lines derived  from PBL of two healthy 
donors (#1: upper  plots and #2: lower  plots). Cells were stained by 2C-IF 
using the VB8-specific  mAb (red fluorescence,  ordinate)  and either a pool 
of VB-specific  mAb (green  fluorescence,  abscissa)  (B) or an irrelevant  V3'9- 
specific  mAb (green fluorescence)  (C). In A, cells  were stained by single- 
color IF with either the VB8-specific  mAb (red) or with the pool of VB- 
specific mAb (green). The two samples were then mixed at a 1:2 ratio 
before flow cytometry  analysis (in this case, although >98% of the cells 
were VB8 +, only one third of them were stained with the V~/8 mAb 
because of the mixing procedure),  mAb included  in the pool  were  specific 
to the following  Vt8 regions: V83, VB5.1, Vt85.2, Vt85.3, VB6.7, Vt812, 
V~19, VB21, and VB22. Note the presence  of double positive cells in B 
(upper right quadrant)  but not in A and C, and the persistence  of FITC- 
labeled cells in A (lower  right quadrant),  which indicated that DP cells  were 
not due to a doublet discrimination  problem or to an artifactual  binding 
of the FITC-conjugated  antiserum to the V~8 mAb. 
ware between a doublet of single positive events and a double 
positive event); and (c) a cross-reactivity of some V/3-specific 
mAbs to other variable regions. The first possibility was ruled 
out by 2C-IF experiments using irrelevant isotype-matched 
mAbs  (Fig.  1 C  and data not shown).  Moreover, the fact 
that no double positive events were detected when analyzing 
mixed samples stained by 1C-IF using either the PE- or FITC- 
conjugated mAbs allowed us to rule out a doublet discrimi- 
nation problem (Fig.  1 A). Finally,  the staining profiles of 
the double positive population was not compatible with cross- 
reactivity of some of the V~/-specific mAbs tested. Instead, 
the inverse correlation noted between staining intensities ob- 
tained with the V~8-specific mAbs vs the pool of V~-specific 
mAbs was strongly indicative of the presence of two distinct 
TCK B chains on the same cell, competing for pairing with 
limiting amounts of other TCR or CD3 components (Fig. 
1 B). 
All T  Cell Clones Recognized by Distinct V~-specific mAbs 
Express Two Distinct Productively  Rearranged TGR ~ Genes.  To 
formally prove the existence of dual B expressors, we gener- 
ated T  cell lines after sequential sorting of PBL using one 
Table  1.  Frequency  of Dual fl Expressors within Cultured 
V~8 § PBLs Estimated by 2C-IF 
Frequency of dual B expressors 
PBL  Observed  Theoretical 
476  0.37  1.23 
765  0.13  0.43 
477  0.15  0.50 
751  0.22  0.73 
767  0.18  0.59 
770  0.17  0.57 
26  0.49  1.63 
27  0.23  0.77 
Mean  0.25  0.83 
Proportions of cells recognized  by two distinct V~/-specific  mAbs among 
eight V38 + PBL-derived  cell lines were calculated by substracting the 
percent double  positive  cells estimated  by 2C-IF using a V3-specific  mAb 
(red) vs an irrelevant mAb (V'y9 specific, green) (see Fig. 1 C) to the 
percent double  positive  cells estimated  by 2C-IF using the VB8 mAb (red) 
vs a pool of mAbs directed against the V33, 5, 6.7, 12, 13.3, 19, 21, 
and 22 regions (green) (see Fig. 1 B). Considering that the pool of VB- 
specific mAb used here recognized  r~30% of PBL (data not shown), the 
theoretical frequency  of dual ~ expressors was deduced by multiplying 
the observed frequency  by 3.33. 
V~-spemfic mAb first and then a pool of mAbs specific for 
other distinct V3 regions (Fig. 2), and cloned them by lim- 
iting dilution. More than 50 clones recognized by two dis- 
tinct V3-specific mAbs were generated this way (see for ex- 
ample,  Fig.  2 D).  It is noteworthy that the relative mean 
fluorescence intensities  (rMFI) obtained with each V3-specific 
mAb, which were calculated by dividing the MH obtained 
with the V3 mAb by the MFI obtained with a pan B mAb, 
greatly varied form one dual B-expressing clone to another 
(Fig. 3 and data not shown). Moreover, within a population 
of clones recognized by the same combination of V3 mAbs 
(e.g., V38 and V319),  the rMFI obtained with each V3- 
specific mAb were inversely correlated (Fig. 3). Again these 
results,  which were reminiscent of those obtained with dual 
TCR 3'- and dual TCR ol chain-expressing clones (14, 33), 
strongly suggested the presence of distinct/3 chains on the 
above cells. 
To formally prove this point, we performed a molecular 
analysis ofTCK 3 transcripts derived from T cell clone RNA, 
after reverse transcription and polymerase chain amplifcation 
using C3- and V3-specific primers followed by sequencing 
of the VDJB junctions. In all cases, surface phenotype of  clones 
recognized by two distinct V3-specific mAbs matched the 
expression of the corresponding productive TCK/3 chain gene 
transcripts (Fig.  4). 
Superantigenic Reactivity of Dual TCR fl Chain Expressors. 
A  salient feature of TCR/3 chains is their ability to inter- 
act via germline residues located in their V region with so- 
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Figmre 2.  Flow cytometry analysis of dual TCR fl 
chain-expressing cells. (.4) 2C-IF analysis of a T cell 
line (flSflX-1)  generated after sequential sorting of PBL 
using a Vfl8-spedfic mAb and a pool of mAbs specific 
to other Vfl regions. The pool of Vfl-specific mAbs 
used for sorting is the same as that in Fig. 1. Note 
the presence of almost all the possible Vfl8VflX com- 
binations in this cell line (see also Table 3). (B) CD8 
coreceptor expression  by dual fl chain expressors. Cells 
from line flSflX-1 were stained with PE-conjugated 
CD8 mAb (ordinate)  and various Vfl-specific mAbs (ab- 
scissa). All cells were recognized by the V38-spedflc 
mAb (see A). Reciprocal results were obtained with 
a PE-conjugated CD4 mAb (data not shown). Note 
that the majority of the subsets recognized by a given 
pair  of Vfl-spedfic  mAbs  comprised  CD4 +  and 
CD8 + cells. (C) 1C-IF analysis  ofVot2 + cells derived 
from line flSflX-1. Cells were sorted using a Vot2.1- 
specific mAb, cultured and analyzed by IF. All cells 
were recognized by the V~2- and Vfl8-specific mAb, 
some were  also recognized by the Vf122-, Vfl21-, 
Vf112-, and Vfl6-specific mAb, which indicated that 
Va2 + cells from line flSflX-1 were still highly poly- 
donal. (/2}) Flow cytometry analysis  of two T cell dones 
derived from line fl8BX-1. Shown are the overlayed 
fluorescence histograms obtained after IF staining of 
two T cell clones (#10, upper histograms and #5, lower 
histograms) using Vfl21-, Vfl6- and Vfl8-specific  mAbs. 
The presence of distinct fl chains in clones #10 and 
#5 was also  confirmed  by molecular  analysis  (see  Fig. 4). 
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Figure 3.  Surface  expression levels  of Vfl8 + and Vf119  + chains on dual 
Vf18Vf119 expressors. The relative mean fluorescence intensities (rMFI) 
obtained with a Vfl8 (ordinate) and a Vfl19-specific  mAb (abscissa), calcu- 
called bacterial  or viral SAgs (that is, staphylococcal entero- 
toxins  or  products  of  the  mouse  mammary  tumor  virus 
[MMTV]-LTR).  We therefore tested whether dual TCR fl 
chain expressors could be activated by SAgs interacting with 
each  of their  surface  fl  chains.  In  humans,  SEB  activates 
Vfl3 +  and Vf119 + cells whereas  SEE activates Vfl8 + cells 
(31,  32,  and  our  own  unpublished  results).  Accordingly, 
Vfl8 + clones proliferated  and produced cytokines when cul- 
tured in the presence of recombinant  SEE but not recom- 
lated by dividing the MFI obtained with the Vfl mAb by the MFI ob- 
tained with a pan fl mAb BMA031 (19), were estimated on two Vfl8 + 
T cell clones {filled circles) and 6 Vf18+Vf119  + T cell clones (unfilled circles). 
Note the inverse correlation between the Vfl8 and Vf119 rMFI within 
the dual fl-expressing cell population. 
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31~3  v~IgVJ~8  19  CASS  FWTGG  SNQPQHF  l.S  8  CAS  STGAGGF  SYEQYF  2.7 
51~1  V~I9V~8  19  CASS  TRGEEV  YNSPLHF  1.6  8  CASS  LAPS  YGY'TT 1.2 
515Z  VplgV136  19  CAS  RQGI  YGYTF 1.Z  6  CASS  PWSP  TKI'GELFF  2.2 
51~3  VI~IgV~3  19  CA  GL  NTEAFF 1.1  3  CAS  ETSGGA  NYGY'TF  1.Z 
5114  V~19V~8  19  f.ASS  IGDIP  YEQYF Z.7  8  C.ASS  TRAAR  QFF  2.1 
5~7  VJ~19Vl]3  19  CAS  GGAYE  QYF  2.7  3  CASS  LPGPS  SYEQYF Z.7 
51~10  V~lgVJ~8  19  CASS  IVPDEHGG  YEQYF  2.7  8  CASS  LQGLV  NTEAFF 1.1 
1  Vp8  Vial2  8  CASS  LSGSG  EKLFF 1.4  1Z  CASS GGLAVLSYG  QYF  2.7 
5  V~8  V~21  8  LASS  FSRGE  SPLHF 1.6  21  CASS PTDFPGTI'A  DTQYF 2.9 
10  Vl~8 Vl~6  8  CASS  LW~rTG'VY  EQFF Z.1  6  CASS  YY'I~GG  EKLFF 1.4 
11  VI~8 V~22  8  CAS  PRRGGGRD  TEAFF  1.1  7.2. CASS  RRGG'VNL  PQHF 1.5 
Figure 4.  Deduced amino acid sequences of TCR B 
chain gene transcripts  expressed in PBbderived T  cell 
clones. The T cell clone phenotyl~ was deduced from IF 
analysis (100% of the cells were recognized by the VB- 
specific mAb mentioned in the figure). These sequence 
data are available  from EMBJ/EBI data bank under acces- 
sion numbers X84265  to X84283. 
binant SEB, whereas reciprocal results were obtained with 
Vf13+V/319  +  clones  (Table 2  and data not  shown).  It  is 
noteworthy that V138  +Vf319  + cells responded to both SEE 
and SEB, which indicated that their two TCR B chains were 
functional (Table 2). 
Frequency of Dual TCR fl Chain Expressors within Human 
PBL.  The frequency of dual B chain expressors was calcu- 
lated from a 2C-IF analysis of VB8 + lines derived from eight 
individuals, under experimental conditions that allowed es- 
timation of frequencies with an accuracy of<0.05%. On av- 
erage,  .25%  of V~8 + cells were recognized by a pool of 
mAbs directed against 10 other V/~ regions (Vfl3, Vfl5.1, 
V~5.2,  VB5.3, Vf16.7,  V~12, Vfl13.3,  VB19,  Vf121, and 
VB22) (Table 1). Considering that these mAbs recognized 
altogether about 30% of PBL, the mean theoretical frequency 
of dual TCR B chain expressors should be dose to 0.8-1.0%. 
Such a high frequency is in accordance with the extensive 
polyclonality of the T cell lines that were generated after se- 
quential sorting using VB8- and the pool of VB-specific  mAbs. 
Indeed, most of the expected Vf38/V~x combinations were 
detected in the majority of the cell lines (Fig. 2 A and Table 
3). Moreover, within a given line, most subsets recognized 
by a-pair of Vfl-specific mAbs comprised CD4+CD8 -  and 
CD4-CD8 + cells (Fig.  2 B and data not shown). Finally, 
IF analysis of Vc~2  + cells derived from the above lines still 
demonstrated the presence of subsets expressing distinct VB 
combinations (Fig.  2 C). 
Discu~ion 
Despite genotypic exclusion of TCR fl chains, which has 
been clearly demonstrated in murine T lymphocytes (5-7), 
and which is likely to occur in human T cells as well, our 
present observations indicate that a significant fraction of pe- 
ripheral lymphocytes in adults carries two distinct functional 
TCR B chains. As for any biological process, an escape from 
TCR fl allelic exclusion was somewhat expected.  However 
Table  2.  Reactivity of Dual TCR ,6 Chain-expressing  T 
Cell Clones towards Staphylococcal SAgs 
[3H]TdR  LIF 
uptake  production 
T  cell clone  Phenotype  SEB  SEE  SEB  SEE 
cpm  x  10 -3  a.u. 
384  V88 +  0.6  13.8  0.0  6.5 
5/33  V83+V819 +  11.1  0.4  5.0  0.0 
587  V83+V819 §  ND  ND  19.5  0.0 
5810  V88 §  §  21.2  22.0  37.0  31.0 
3/33  V/38+V819 +  13.3  17.8  7.0  8.0 
T cell clones were cultured with irradiated MHC class ll-positive Raji 
Burkitt's lymphoma cells in the absence or presence of either recombinant 
SEE or SEB (SAg). LIF activity in the culture supernatant was estimated 
by a biological assay (29) and expressed as arbitrary  units (a.u) per ml. 
None of the clones tested produced LIF when cultured with Raji cells 
alone (data not shown).  T cell clone proliferative response to SAg was 
calculated by substracting the 13H]TdR uptake estimated after coculture 
with Raji cells alone to the [3H]Tdr uptake estimated  after coculture 
with Raji and SAg. Note the response of V38+V319 + T cell clones to 
both the SEE and SEB. 
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Table  3.  TCR  V~ Surface Expression of PBL.derived Lines 
Generated after Sequential Sorting Using a  V~8-specific mAb First 
and then a Pool of raAbs Specific to V~3,  5,  6,  8,  12,  13,  19, 
21, and 22 
PBL line V83  V85  V86  V88  V812  V813  V819  V821  V822 
888X-1  0.2  3.8  14.4  98.0  34.7  0.5  31.3  7.2  2.5 
88BX-2  4.5  0.2  7.6  99.1  58.1  0.2  7.5  9.4  4.4 
888X-3  2.4  1.1  39.9  99.9  1.9  0.3  11.0  14.0  23.8 
888X-4  7.9  2.6  10.5  99.9  14.5  0.1  29.4  8.5  20.6 
Note that subsets expressing most possible VB8V~X combinations are 
detected in most lines, attesting to their extensive polyclonality. In each 
of these cell lines, we could demonstrate  the presence of at least 10-15 
distinct clones differing by the Vfl combination  expressed and CD4/CD8 
coreceptor  expression.  Since all these  lines  were  generated  from  10  s 
VB8 § cells, the minimal observed frequency is 91-1.5  x  10 -4.  The 
10-20-fold difference between this minimal estimate and the frequency 
deduced from flow cytometry analyses (Fig. 1) is easily explained by the 
fact that (a) clones were defined on the basis of two criteria only (Vii 
combination and coreceptor expression); (b) our sorting ef~ciency was 
much below 100% (under standard conditions it was at most 20%, our 
unpublished observations); and (c) the starting population was probably 
not composed of distinct clones. the relatively high frequency of dual 3  expressors  estimated 
here (that is, close to 1%) raises questions regarding its phys- 
iological consequences and the way cells with such an un- 
usual phenotype were generated. 
Rearrangements of TCR 3 genes are activated within early 
CD3-CD4-CD8-  thymocytes. At that stage, expression of 
any productively rearranged 3 chain gene will lead to a tran- 
sient arrest of the thymocyte recombination machinery, pre- 
sumably upon pairing between the ~ chain gene product and 
a surrogate c~ chain (35).  TCR ol gene rearrangements are 
activated at  a  later  stage of development (that  is,  within 
CD4+CD8 + thymocytes), when the 3 loci are no longer ac- 
cessible to the recombinases. According to this scheme, three 
major hypotheses might be put forward to account for the 
generation of dual TCR ~ chain expressors. First, escape from 
fl genotypic exclusion might be due to an intrinsic inability 
of the first  fl  chain  produced to  generate a  recombinase 
modulating signal. However, this possibility  seems rather un- 
likely because such a signal can even be provided by trun- 
cated fl chains (7) and because both the fl chains on dual 
expressors  were shown to be functional (Table 2).  Second, 
escape from ~ chain exclusion might happen if for some un- 
known reasons, rearrangements occur synchronously on the 
two ~  alleles or if signaling through the first fl chain pro- 
duced is delayed. Third, an accessibility of the fl loci to the 
recombinases at  an abnormally late stage of development 
(that is, at the CD4 +  CD8 + stage) might result in secondary 
TCR ~  rearrangements. 
As mentioned, one might expect the frequency of cells with 
two receptors with distinct physiologically relevant specificities 
to be higher among dual B than dual oe expressors. However, 
it is likely that for several reasons exposed below, a relatively 
high incidence of dual 3 expressors (even in the order of 1%) 
will have limited consequences on a normal immune func- 
tion. First, as mentioned previously, current models suggest 
that a thymocyte will stop its recombination machinery once 
it has produced a selectable oe chain, able to form a receptor 
with sufIident affinity for selfMHC-peptides. Consequently, 
the fact that T  cells have almost systematically rearranged 
their two ot alleles (6) would indicate that in most cases, the 
first c~ chain produced was unable to generate a recombina- 
tion modulating signal, which would mean that the propor- 
tion of selectable o~/3 TCR within the immature (unselected) 
repertoire is extremely low. Therefore, the probability that 
both TCR on dual 3 expressors will be self MHC restricted 
(that is, physiologically relevant) should be almost negligible. 
Second, even if a dual expressor turned out to be plurispecific, 
it would likely be controlled by the powerful negative selec- 
tion processes operating in the thymus and in the periphery. 
Third,  although the in vivo significance of superantigenic 
responses is yet unclear, the fact that  the immune system 
tolerates a relatively high frequency of clones truly bispecific 
towards distinct SAgs might indicate that donal plurispecificity 
has limited consequences in terms of immune response spec- 
ificity. Fourth and more importantly, demonstration of the 
functionality of the two TCRs present on dual c,, B, or 7 
expressors  in in vitro assays may not necessarily mean that 
these cells can be efficiently activated in vivo via each of their 
surface receptors. In this respect, several indirect observations 
suggest that cells expressing a single surface receptor have 
a strong selective advantage over dual TCR expressors.  For 
instance, in transgenic mice carrying several copies of an Ig 
light chain transgene, because each copy is independently 
hypermutated in the course of the Ig affinity maturation pro- 
cess, any B cell from these animals should express different 
transgenic light chains on its surface.  In fact only those B 
cells expressing a single transgenic chain (the one conferring 
a high affinity for the selecting antigen), but having pheno- 
typically excluded the improperly mutated ones, are amplified 
during secondary B cell responses (36).  Similarly a prelimi- 
nary analysis of human peripheral 3"/~ T  cells suggests the 
occurrence of a 3' chain phenotypic exclusion within subsets 
subjected to an in vivo peripheral selection (our own unpub- 
lished observations). The hypothesis of a phenotypic exclu- 
sion occurring during selection of mature T cells might well 
explain the apparent discrepancies between observations made 
on human vs murine T cells. Indeed, whereas a relatively high 
incidence of dual ~ (14) or dual ~ expressors (this study) has 
been observed within human PBL, routine T cell clones were 
generally shown to express a single TCR c~ chain on their 
surface, despite the presence of two productive TCR ol rear- 
rangements in a large fraction of them (6).  Similarly, dual 
~/expression in the mouse has been thus far formally proven 
in one case only (37).  Since in most murine studies, unlike 
human ones, clones have been selected in vivo or in vitro 
by specific antigenic stimuli before analysis, an antigen-driven 
phenotypic exclusion might have occurred in the former, but 
not the latter case. A recent study, which demonstrates that 
within T cells expressing identical TCRs partial modulation 
of CD8 coreceptors on the responding cells converts an agonist 
Ag into an antagonist one (38), may provide some clues on 
the way dual TCR expressors  (which express  intermediate 
levels of each TCR) would be eliminated or diluted out in 
the course of an antigen response. 
All the above considerations suggest that to an extreme 
point of view, allelic exclusion is not meant to ensure clonal 
monospecificity. However, they also suggest that expression 
of multiple receptors on the same cell may constitute a disad- 
vantage in the course of antigen-driven selection of periph- 
eral T cells.  Therefore, the occurrence of a control mecha- 
nism limiting the heterogeneity of the TCR B chains expressed 
on the T cell clone surface should greatly improve the e~ciency 
of central and peripheral T  cell selection. 
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